Imiquimod 5% cream for the treatment of actinic keratosis: Results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology-Reference-Cited by-同舟云学术

Imiquimod 5% cream for the treatment of actinic keratosis: Results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology

Published:2004-10 Issue:4 Volume:51 Page:547-555
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Szeimies Rolf-Markus,Gerritsen Marie-Jeanne P.,Gupta Girish,Ortonne Jean Paul,Serresi Stefano,Bichel Jens,Lee James H.,Fox Terry L.,Alomar Agustı́n

Publisher

Elsevier BV

Subject

Dermatology

Reference14 articles.

1. Actinic keratosis;Callen;J Am Acad Dermatol,1997

2. Incipient intraepidermal cutaneous squamous cell carcinoma: a proposal for reclassifying and grading solar (actinic) keratoses;Yantsos;Semin Cutan Med Surg,1999

3. Solar keratoses and their relationship to non-melanoma skin cancers;Kocsard;Australas J Dermatol,1997

4. Nudging epidermal field cancerogenesis by imiquimod;Uhoda;Dermatology,2003

5. Incidental histopathologic pattern: possible evidence of field cancerisation surrounding skin tumors;Carlson;Am J Dermatopathol,2001

Cited by 173 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review of randomized controlled trials of topicals for actinic keratosis field therapy;Archives of Dermatological Research;2024-03-18

2. Development and application of an in vitro assay to assess target-independent B-cell activation by targeted TLR7 immune agonists;Journal of Immunological Methods;2023-11

3. Imiquimod as Local Immunotherapy in the Management of Premalignant Cutaneous Conditions and Skin Cancer;International Journal of Molecular Sciences;2023-06-29

4. Poor Adherence to Self-Applied Topical Drug Treatment Is a Common Source of Low Lesion Clearance in Patients with Actinic Keratosis—A Cross-Sectional Study;Journal of Clinical Medicine;2023-06-01

5. Immunomodulators for Non-Melanoma Skin Cancers: Updated Perspectives;Clinical, Cosmetic and Investigational Dermatology;2023-04